For: | Ma ZH, Wang XM, Wu RH, Hao DL, Sun LC, Li P, Niu JQ. Serum metabolic profiling of targeted bile acids reveals potentially novel biomarkers for primary biliary cholangitis and autoimmune hepatitis. World J Gastroenterol 2022; 28(39): 5764-5783 [PMID: PMC9627419 DOI: 10.3748/wjg.v28.i39.5764] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v28/i39/5764.htm |
Number | Citing Articles |
1 |
Paul‐Henry Koop, Constanze Schwenzer, Jan Clusmann, Mara S. Vell, Julius Jaeger, Wenfang Gui, Christian Trautwein, Alexander Koch, Tony Bruns, Carolin V. Schneider, Kai Markus Schneider. Comorbidities, mortality and metabolic profile in individuals with primary biliary cholangitis—A Phenome‐Wide‐Association‐Study. Liver International 2024; 44(8): 2038 doi: 10.1111/liv.15945
|
2 |
Masahiro Umemura, Akira Honda, Maho Yamashita, Takeshi Chida, Hidenao Noritake, Kenta Yamamoto, Takashi Honda, Mayuko Ichimura-Shimizu, Koichi Tsuneyama, Teruo Miyazaki, Nobuhito Kurono, Patrick S.C. Leung, M. Eric Gershwin, Takafumi Suda, Kazuhito Kawata. High-fat diet modulates bile acid composition and gut microbiota, affecting severe cholangitis and cirrhotic change in murine primary biliary cholangitis. Journal of Autoimmunity 2024; 148: 103287 doi: 10.1016/j.jaut.2024.103287
|
3 |
Zhenhua Liu, Chongge You. The bile acid profile. Clinica Chimica Acta 2025; 565: 120004 doi: 10.1016/j.cca.2024.120004
|
4 |
Meng Zhu, Linghui Tao, Feiye Zhu, Yongsheng Zhang. A Comparative Analysis of ADRs under Obeticholic Acid and
Ursodeoxycholic Acid in Cholestatic Liver Diseases Using the FAERS
Database. Drug Research 2024; 74(09): 464 doi: 10.1055/a-2401-4700
|